Literature DB >> 15609177

Health-based risk adjustment Improving the pharmacy-based cost group model to reduce gaming possibilities.

L M Lamers1, R C J A Vliet.   

Abstract

The pharmacy-based cost group (PCG) model uses medication prescribed to individuals in a base-year as marker for chronic conditions which are employed to adjust capitation payments to their health plans in the subsequent year. Although the PCG model enhances predictive performance, possibilities for gaming may arise as it is based on prior utilization. This study investigates several strategies to mitigate this problem. The best strategies appear to be: use a (high) number of prescribed daily doses to assign persons to PCGs, do not allow for comorbidity, and remove PCGs with low future costs. This PCG model accounts for almost twice as much variance as do demographic models. In 2002 the Dutch government implemented this model in the sickness fund sector (two-thirds of the population).

Entities:  

Year:  2003        PMID: 15609177     DOI: 10.1007/s10198-002-0159-9

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  16 in total

1.  Overpaying morbidity adjusters in risk equalization models.

Authors:  R C van Kleef; R C J A van Vliet; W P M M van de Ven
Journal:  Eur J Health Econ       Date:  2015-09-29

2.  Empirically derived weights for GMS capitation payments to General Practitioners.

Authors:  B McElroy
Journal:  Ir J Med Sci       Date:  2017-01-18       Impact factor: 1.568

3.  Improving the prediction model used in risk equalization: cost and diagnostic information from multiple prior years.

Authors:  S H C M van Veen; R C van Kleef; W P M M van de Ven; R C J A van Vliet
Journal:  Eur J Health Econ       Date:  2014-02-12

4.  Change in colorectal cancer (CRC) testing rates associated with the introduction of the first organized screening program in canton Uri, Switzerland: Evidence from insurance claims data analyses from 2010 to 2018.

Authors:  Sarah Bissig; Lamprini Syrogiannouli; Rémi Schneider; Kali Tal; Kevin Selby; Cinzia Del Giovane; Jean-Luc Bulliard; Oliver Senn; Cyril Ducros; Christian P R Schmid; Urs Marbet; Reto Auer
Journal:  Prev Med Rep       Date:  2022-06-10

5.  Improving the Performance of Risk Adjustment Systems: Constrained Regressions, Reinsurance, and Variable Selection.

Authors:  Thomas G McGuire; Anna L Zink; Sherri Rose
Journal:  Am J Health Econ       Date:  2021-10-04

6.  A comparison of Australian chronic disease prevalence estimates using administrative pharmaceutical dispensing data with international and community survey data.

Authors:  Shaun Francis Purkiss; Tessa Keegel; Hassan Vally; Dennis Wollersheim
Journal:  Int J Popul Data Sci       Date:  2020-12-11

7.  An empirical investigation of the efficiency effects of integrated care models in Switzerland.

Authors:  Oliver Reich; Roland Rapold; Magdalena Flatscher-Thöni
Journal:  Int J Integr Care       Date:  2012-01-13       Impact factor: 5.120

8.  Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications.

Authors:  Carola A Huber; Thomas D Szucs; Roland Rapold; Oliver Reich
Journal:  BMC Public Health       Date:  2013-10-30       Impact factor: 3.295

9.  Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool.

Authors:  David Vivas-Consuelo; Ruth Usó-Talamantes; Natividad Guadalajara-Olmeda; José-Luis Trillo-Mata; Carla Sancho-Mestre; Laia Buigues-Pastor
Journal:  BMC Health Serv Res       Date:  2014-10-21       Impact factor: 2.655

10.  Inappropriate use of arthroscopic meniscal surgery in degenerative knee disease.

Authors:  Leander L S Muheim; Oliver Senn; Mathias Früh; Oliver Reich; Thomas Rosemann; Stefan M Neuner-Jehle
Journal:  Acta Orthop       Date:  2017-06-30       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.